Syntaxin 18 regulates the DNA damage response and epithelial-to-mesenchymal transition to promote radiation resistance of lung cancer

Abstract Radiotherapy is an important modality in lung cancer treatment. Despite advances in treatment planning and dose delivery, patient benefit is still limited by in-field relapse and metastatic recurrence. Simultaneous application of cisplatinum-based chemotherapy leads to moderately improved o...

Full description

Bibliographic Details
Main Authors: Clotilde Thumser-Henner, Sebastian Oeck, Sophie Kalmbach, Jan Forster, Franziska Kindl, Ali Sak, Alexander Schramm, Martin Schuler
Format: Article
Language:English
Published: Nature Publishing Group 2022-06-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-022-04978-4
_version_ 1811258041980420096
author Clotilde Thumser-Henner
Sebastian Oeck
Sophie Kalmbach
Jan Forster
Franziska Kindl
Ali Sak
Alexander Schramm
Martin Schuler
author_facet Clotilde Thumser-Henner
Sebastian Oeck
Sophie Kalmbach
Jan Forster
Franziska Kindl
Ali Sak
Alexander Schramm
Martin Schuler
author_sort Clotilde Thumser-Henner
collection DOAJ
description Abstract Radiotherapy is an important modality in lung cancer treatment. Despite advances in treatment planning and dose delivery, patient benefit is still limited by in-field relapse and metastatic recurrence. Simultaneous application of cisplatinum-based chemotherapy leads to moderately improved outcomes, thus providing proof-of-concept for radiosensitization strategies in lung cancer. In an unbiased functional genetic screen for radiosensitization targets in lung cancer, we identified syntaxin 18, a protein involved in retrograde vesicular transport between the Golgi apparatus and endoplasmic reticulum, as mediator of radioresistance. Downregulation of endogenous syntaxin 18 specifically reduced clonogenic survival of radioresistant and radiosensitive lung cancer cells following X-radiation. Gene expression programs regulating DNA repair, mitotic checkpoints and mitosis were altered in isogenic cells with reduced syntaxin 18 expression. Functionally, this translated into impaired DNA damage-induced cell cycle checkpoints leading to cell death by mitotic catastrophe. Interestingly, downregulation of syntaxin 18 in lung cancer cells also impaired expression of markers of epithelial-mesenchymal-transition, and reduced migration and invasion capacity. These findings suggest that syntaxin 18 is a key player regulating genes responsible for controlling the growth of the primary tumor as well as metastases upon radiotherapy of lung cancer. They provide a promising lead for biologically rational radiosensitization strategies impacting on radiation-induced cell death as well as metastasis.
first_indexed 2024-04-12T18:07:12Z
format Article
id doaj.art-44dc9a67e42f49ab9888e498a0f3cf72
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-04-12T18:07:12Z
publishDate 2022-06-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-44dc9a67e42f49ab9888e498a0f3cf722022-12-22T03:21:57ZengNature Publishing GroupCell Death and Disease2041-48892022-06-0113611110.1038/s41419-022-04978-4Syntaxin 18 regulates the DNA damage response and epithelial-to-mesenchymal transition to promote radiation resistance of lung cancerClotilde Thumser-Henner0Sebastian Oeck1Sophie Kalmbach2Jan Forster3Franziska Kindl4Ali Sak5Alexander Schramm6Martin Schuler7Laboratory of Molecular Oncology, Department of Medical Oncology, West German Cancer Center, University Hospital EssenLaboratory of Molecular Oncology, Department of Medical Oncology, West German Cancer Center, University Hospital EssenLaboratory of Molecular Oncology, Department of Medical Oncology, West German Cancer Center, University Hospital EssenGerman Cancer Consortium (DKTK), Partner site University Hospital EssenLaboratory of Molecular Oncology, Department of Medical Oncology, West German Cancer Center, University Hospital EssenDepartment of Radiotherapy, University Hospital EssenLaboratory of Molecular Oncology, Department of Medical Oncology, West German Cancer Center, University Hospital EssenLaboratory of Molecular Oncology, Department of Medical Oncology, West German Cancer Center, University Hospital EssenAbstract Radiotherapy is an important modality in lung cancer treatment. Despite advances in treatment planning and dose delivery, patient benefit is still limited by in-field relapse and metastatic recurrence. Simultaneous application of cisplatinum-based chemotherapy leads to moderately improved outcomes, thus providing proof-of-concept for radiosensitization strategies in lung cancer. In an unbiased functional genetic screen for radiosensitization targets in lung cancer, we identified syntaxin 18, a protein involved in retrograde vesicular transport between the Golgi apparatus and endoplasmic reticulum, as mediator of radioresistance. Downregulation of endogenous syntaxin 18 specifically reduced clonogenic survival of radioresistant and radiosensitive lung cancer cells following X-radiation. Gene expression programs regulating DNA repair, mitotic checkpoints and mitosis were altered in isogenic cells with reduced syntaxin 18 expression. Functionally, this translated into impaired DNA damage-induced cell cycle checkpoints leading to cell death by mitotic catastrophe. Interestingly, downregulation of syntaxin 18 in lung cancer cells also impaired expression of markers of epithelial-mesenchymal-transition, and reduced migration and invasion capacity. These findings suggest that syntaxin 18 is a key player regulating genes responsible for controlling the growth of the primary tumor as well as metastases upon radiotherapy of lung cancer. They provide a promising lead for biologically rational radiosensitization strategies impacting on radiation-induced cell death as well as metastasis.https://doi.org/10.1038/s41419-022-04978-4
spellingShingle Clotilde Thumser-Henner
Sebastian Oeck
Sophie Kalmbach
Jan Forster
Franziska Kindl
Ali Sak
Alexander Schramm
Martin Schuler
Syntaxin 18 regulates the DNA damage response and epithelial-to-mesenchymal transition to promote radiation resistance of lung cancer
Cell Death and Disease
title Syntaxin 18 regulates the DNA damage response and epithelial-to-mesenchymal transition to promote radiation resistance of lung cancer
title_full Syntaxin 18 regulates the DNA damage response and epithelial-to-mesenchymal transition to promote radiation resistance of lung cancer
title_fullStr Syntaxin 18 regulates the DNA damage response and epithelial-to-mesenchymal transition to promote radiation resistance of lung cancer
title_full_unstemmed Syntaxin 18 regulates the DNA damage response and epithelial-to-mesenchymal transition to promote radiation resistance of lung cancer
title_short Syntaxin 18 regulates the DNA damage response and epithelial-to-mesenchymal transition to promote radiation resistance of lung cancer
title_sort syntaxin 18 regulates the dna damage response and epithelial to mesenchymal transition to promote radiation resistance of lung cancer
url https://doi.org/10.1038/s41419-022-04978-4
work_keys_str_mv AT clotildethumserhenner syntaxin18regulatesthednadamageresponseandepithelialtomesenchymaltransitiontopromoteradiationresistanceoflungcancer
AT sebastianoeck syntaxin18regulatesthednadamageresponseandepithelialtomesenchymaltransitiontopromoteradiationresistanceoflungcancer
AT sophiekalmbach syntaxin18regulatesthednadamageresponseandepithelialtomesenchymaltransitiontopromoteradiationresistanceoflungcancer
AT janforster syntaxin18regulatesthednadamageresponseandepithelialtomesenchymaltransitiontopromoteradiationresistanceoflungcancer
AT franziskakindl syntaxin18regulatesthednadamageresponseandepithelialtomesenchymaltransitiontopromoteradiationresistanceoflungcancer
AT alisak syntaxin18regulatesthednadamageresponseandepithelialtomesenchymaltransitiontopromoteradiationresistanceoflungcancer
AT alexanderschramm syntaxin18regulatesthednadamageresponseandepithelialtomesenchymaltransitiontopromoteradiationresistanceoflungcancer
AT martinschuler syntaxin18regulatesthednadamageresponseandepithelialtomesenchymaltransitiontopromoteradiationresistanceoflungcancer